Works by Hendricks, William P. D.

Results: 16
    1
    2
    3

    Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis.

    Published in:
    PLoS Genetics, 2018, v. 14, n. 9, p. 1, doi. 10.1371/journal.pgen.1007589
    By:
    • Hendricks, William P. D.;
    • Zismann, Victoria;
    • Sivaprakasam, Karthigayini;
    • Legendre, Christophe;
    • Poorman, Kelsey;
    • Tembe, Waibhav;
    • Perdigones, Nieves;
    • Kiefer, Jeffrey;
    • Liang, Winnie;
    • DeLuca, Valerie;
    • Stark, Mitchell;
    • Ruhe, Alison;
    • Froman, Roe;
    • Duesbery, Nicholas S.;
    • Washington, Megan;
    • Aldrich, Jessica;
    • Neff, Mark W.;
    • Huentelman, Matthew J.;
    • Hayward, Nicholas;
    • Brown, Kevin
    Publication type:
    Article
    4

    A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma.

    Published in:
    Cancer Reports, 2022, v. 5, n. 11, p. 1, doi. 10.1002/cnr2.1616
    By:
    • Kraveka, Jacqueline M.;
    • Lewis, Elizabeth C.;
    • Bergendahl, Genevieve;
    • Ferguson, William;
    • Oesterheld, Javier;
    • Kim, Elizabeth;
    • Nagulapally, Abhinav B.;
    • Dykema, Karl J.;
    • Brown, Valerie I.;
    • Roberts, William D.;
    • Mitchell, Deanna;
    • Eslin, Don;
    • Hanson, Derek;
    • Isakoff, Michael S.;
    • Wada, Randal K.;
    • Harrod, Virginia L.;
    • Rawwas, Jawhar;
    • Hanna, Gina;
    • Hendricks, William P. D.;
    • Byron, Sara A.
    Publication type:
    Article
    5
    6

    Genomic landscapes of canine splenic angiosarcoma (hemangiosarcoma) contain extensive heterogeneity within and between patients.

    Published in:
    PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0264986
    By:
    • Wong, Shukmei;
    • Ehrhart, E. J.;
    • Stewart, Samuel;
    • Zismann, Victoria;
    • Cawley, Jacob;
    • Halperin, Rebecca;
    • Briones, Natalia;
    • Richter, Keith;
    • Sivaprakasam, Karthigayini;
    • Perdigones, Nieves;
    • Contente-Cuomo, Tania;
    • Facista, Salvatore;
    • Trent, Jeffrey M.;
    • Murtaza, Muhammed;
    • Khanna, Chand;
    • Hendricks, William P. D.
    Publication type:
    Article
    7
    8
    9

    Identifying treatment options for BRAF<sup>V600</sup> wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.

    Published in:
    PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0248097
    By:
    • LoRusso, Patricia M.;
    • Sekulic, Aleksandar;
    • Sosman, Jeffrey A.;
    • Liang, Winnie S.;
    • Carpten, John;
    • Craig, David W.;
    • Solit, David B.;
    • Bryce, Alan H.;
    • Kiefer, Jeffrey A.;
    • Aldrich, Jessica;
    • Nasser, Sara;
    • Halperin, Rebecca;
    • Byron, Sara A.;
    • Pilat, Mary Jo;
    • Boerner, Scott A.;
    • Durecki, Diane;
    • Hendricks, William P. D.;
    • Enriquez, Daniel;
    • Izatt, Tyler;
    • Keats, Jonathan
    Publication type:
    Article
    10

    Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC.

    Published in:
    Veterinary & Comparative Oncology, 2023, v. 21, n. 3, p. 482, doi. 10.1111/vco.12911
    By:
    • Sakthikumar, Sharadha;
    • Facista, Salvatore;
    • Whitley, Derick;
    • Byron, Sara A.;
    • Ahmed, Zeeshan;
    • Warrier, Manisha;
    • Zhu, Zhanyang;
    • Chon, Esther;
    • Banovich, Kathryn;
    • Haworth, David;
    • Hendricks, William P. D.;
    • Wang, Guannan
    Publication type:
    Article
    11

    Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism.

    Published in:
    eLife, 2021, p. 1, doi. 10.7554/eLife.59073
    By:
    • Orlando, Krystal Ann;
    • Douglas, Amber K.;
    • Abudu, Aierken;
    • Wang, Yemin;
    • Tessier-Cloutier, Basile;
    • Su, Weiping;
    • Peters, Alec;
    • Sherman, Larry S.;
    • Moore, Rayvon;
    • Nguyen, Vinh;
    • Negri, Gian Luca;
    • Colborne, Shane;
    • Morin, Gregg B.;
    • Kommoss, Friedrich;
    • Lang, Jessica D.;
    • Hendricks, William P. D.;
    • Raupach, Elizabeth A.;
    • Pirrotte, Patrick;
    • Huntsman, David G.;
    • Trent, Jeffrey M.
    Publication type:
    Article
    12
    13

    The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.

    Published in:
    PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0235705
    By:
    • Soldi, Raffaella;
    • Ghosh Halder, Tithi;
    • Weston, Alexis;
    • Thode, Trason;
    • Drenner, Kevin;
    • Lewis, Rhonda;
    • Kaadige, Mohan R.;
    • Srivastava, Shreyesi;
    • Daniel Ampanattu, Sherin;
    • Rodriguez del Villar, Ryan;
    • Lang, Jessica;
    • Vankayalapati, Hariprasad;
    • Weissman, Bernard;
    • Trent, Jeffrey M.;
    • Hendricks, William P. D.;
    • Sharma, Sunil
    Publication type:
    Article
    14

    Corrigendum: Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.

    Published in:
    Nature Genetics, 2014, v. 46, n. 7, p. 759, doi. 10.1038/ng0714-759a
    By:
    • Ramos, Pilar;
    • Karnezis, Anthony N;
    • Craig, David W;
    • Sekulic, Aleksander;
    • Russel, Megan L;
    • Hendricks, William P D;
    • Corneveaux, Jason J;
    • Barrett, Michael T;
    • Shumansky, Karey;
    • Yang, Yidong;
    • Shah, Sohrab P;
    • Prentice, Leah M;
    • Marra, Marco A;
    • Kiefer, Jeffrey;
    • Zismann, Victoria L;
    • McEachron, Troy A;
    • Salhia, Bodour;
    • Prat, Jaime;
    • D'Angelo, Emanuela;
    • Clarke, Blaise A
    Publication type:
    Article
    15

    Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.

    Published in:
    Nature Genetics, 2014, v. 46, n. 5, p. 427, doi. 10.1038/ng.2928
    By:
    • Ramos, Pilar;
    • Karnezis, Anthony N;
    • Craig, David W;
    • Sekulic, Aleksandar;
    • Russell, Megan L;
    • Hendricks, William P D;
    • Corneveaux, Jason J;
    • Barrett, Michael T;
    • Shumansky, Karey;
    • Yang, Yidong;
    • Shah, Sohrab P;
    • Prentice, Leah M;
    • Marra, Marco A;
    • Kiefer, Jeffrey;
    • Zismann, Victoria L;
    • McEachron, Troy A;
    • Salhia, Bodour;
    • Prat, Jaime;
    • D'Angelo, Emanuela;
    • Clarke, Blaise A
    Publication type:
    Article
    16

    E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 4, p. 636, doi. 10.1007/s10637-018-0668-8
    By:
    • Babiker, Hani M.;
    • Byron, Sara A.;
    • Hendricks, William P. D.;
    • Elmquist, William F.;
    • Gampa, Gautham;
    • Vondrak, Jessica;
    • Aldrich, Jessica;
    • Cuyugan, Lori;
    • Adkins, Jonathan;
    • De Luca, Valerie;
    • Tibes, Raoul;
    • Borad, Mitesh J.;
    • Marceau, Katie;
    • Myers, Thomas J.;
    • Paradiso, Linda J.;
    • Liang, Winnie S.;
    • Korn, Ronald L.;
    • Cridebring, Derek;
    • Von Hoff, Daniel D.;
    • Carpten, John D.
    Publication type:
    Article